Citation Impact
Citing Papers
Self-help interventions for depressive disorders and depressive symptoms: a systematic review
2008
The myc Oncogene: arvelouslomplex
2002
Advances in stem cell mobilization
2014
Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib
2010
Direct observation of individual endogenous protein complexes in situ by proximity ligation
2006 Standout
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
2010
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Neutrophils at work
2014 Standout
Advances in stem cell mobilization
2012
Cancer drug resistance: an evolving paradigm
2013 Standout
Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients
2003 Standout
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability
2008
Retinoids in cancer therapy.
1992
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
2012
Apoptosis
2002 Standout
Antisense therapy in oncology: new hope for an old idea?
2001
The validity of the Hospital Anxiety and Depression Scale
2002 Standout
Mental health literacy: Empowering the community to take action for better mental health.
2011 Standout
Reflecting on 25 years with MYC
2008 Standout
Head and Neck Cancer
1993 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
The Hospital Anxiety And Depression Scale.
2003 Standout
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Global meaning and psychological adjustment among survivors of bone marrow transplant
2001
Making sense of the meaning literature: An integrative review of meaning making and its effects on adjustment to stressful life events.
2010 Standout
Specific Killing of Ph+Chronic Myeloid Leukemia Cells by a Lentiviral Vector-Delivered Anti-bcr/ablSmall Hairpin RNA
2003
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review)
2009
Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies
2000
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products
2003
Multiple Sclerosis
2018 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
2007
Health-Related Quality of Life 1 Year After Allogeneic or Autologous Stem-Cell Transplantation: A Prospective Study
1999
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results
1997 Standout
Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications
2001 Standout
Works of R E Clark being referenced
Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters
2009
Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system
1998
Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems
2000
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)
2014
Vitamin C, Mood and Cognitive Functioning in the Elderly
1999
High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMV
2001
Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
2006
Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia
1999
Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia
2007
Psychosocial morbidity in bone marrow transplant recipients: a prospective study.
1995
13-cis-retinoic acid v placebo in myelodysplasia [letter]
1988